Keralty S.A.S and Burjeel Holdings have announced a joint venture aimed at establishing a unique healthcare model for cost-efficient healthcare solutions. The joint venture, AL KALMA, was announced at a signing ceremony held in Cartagena de Indias, Colombia. The alliance aims to enhance well-being throughout the value chain by promoting access to high-quality healthcare at an affordable price.

AL KALMA, a name that signifies 'united for health and well-being', will consolidate a unique value-based healthcare model with specialized primary care centers, health risk management, and a new range of integrated mental health services, expecting to reach nearly 30 million patients over the next decade. The strategic partnership combines the experience and knowledge of both groups for a rapid roll-out in the Middle East, with the potential to extend subsequently into North Africa. The joint venture will debut in Saudi Arabia, leveraging the shift in the Saudi healthcare market towards a primary healthcare model.

The collaboration aims to extend services beyond the region by evaluating each market and executing the strategy on a country-by-country basis. Keralty, with a track record of nearly five decades and operations in nine countries, including the US and Burjeel Holdings, enters into this joint venture by leveraging the success of its healthcare model based on the prevention, detection, and management of health risks, as well as the control and care of diseases and dependency. Burjeel Holdings, with a strong presence in the Middle East, offers the highest standards of care through an integrated network of hospitals, medical centers, and pharmacies, focusing on highly complex and specialized services.

The partnership announcement ceremony was attended by H.E. Mohammed Abdullah bin Khater Al Shamsi, Ambassador of the United Arab Emirates to the Republic of Colombia; Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings; Mr. John Sunil, CEO of Burjeel Holdings; along with Mr. Joseba Grajales, President of Keralty and Dr. Emilio Herrera, CHO of Keralty. The joint venture partnership will be operated through a newly formed holding company established in the Abu Dubai Global Market jurisdiction. Keralty and Burjeel Holdings will each hold an equal 50% shareholding.

Further information, including details of the expansion plan, will be disclosed in due course. Through AL KALMA, Keralty and BurjeEL demonstrate their commitment to improving global health by providing access to quality healthcare and fostering well-being, sustainability, and efficiency. With a network of 82 assets, including 17 hospitals and 42 medical centers, as well as 15 pharmacies and other allied services, the Group collectively provides a premier offering in the Gulf region.

Burjeel Holdings' brands include Burjeel, Medeor, LLH, Lifecare, PhysioTherabia and Tajmeel. It has 13 JCI-accredited facilities, with a total of 1,708 patient beds across its operations in the UAE and Oman and holds a leading position in the UAE.